Formerly the Bay Area Global Health Alliance

contact us
Join Us
Subscribe

Search

Events
MEMBERS
Show Members
TOPICS
REGIONS
Outcomes-Based Financing: A Novel Tool in the Fight Against AMR | PATH and Partners Share New Research and Model to Drive Responsible Antibiotic Use

Outcomes-Based Financing: A Novel Tool in the Fight Against AMR | PATH and Partners Share New Research and Model to Drive Responsible Antibiotic Use

At a recent Clinton Global Initiative (CGI) Deeper Dive Session,  PATH — together with Pfizer, the Bay Area Global Health Alliance, and Social Finance International — shared early-phase research findings aimed at understanding the drivers of antibiotic misuse and presented an innovative financing design approach to incentivize the correct use of antibiotics. The session aimed to raise awareness and engage potential partners around a next-phase pilot to test outcomes-based financing (OBF) as a new tool to drive more sustainable and effective stewardship.

Tackling AMR with Outcomes-Based Financing: Findings from Tanzania and Senegal

Tackling AMR with Outcomes-Based Financing: Findings from Tanzania and Senegal

On February 25, Neha Agarwal, senior director of strategy at PATH and Alliance board vice chair, led a session for Stanford Mussallem Center for Biodesign’s Innovation and Health Equity Series. She discussed how outcomes-based financing (OBF) can be leveraged to tackle antimicrobial resistance (AMR). Her talk, which provided a first look at data from a year-long study in Tanzania and Senegal, emphasized how innovative financing mechanisms could reshape global health strategies.

Outcomes-Based Finance as a Tool for Health Equity and Innovation

Outcomes-Based Finance as a Tool for Health Equity and Innovation

, ,

Join Stanford Mussallem Center for Biodesign on February 25 for the next session in their Innovation and Health Equity Discussion Series where Neha Agarwal, senior director of strategy at PATH and Alliance board vice chair, will discuss an innovative outcomes-based financing (OBF) mechanism being developed in partnership with the governments of Tanzania and Senegal, the Bay Area Global Health Alliance, and Pfizer to reinforce antimicrobial stewardship efforts in LMICs.